Determination of tumor cell procoagulant activity by Sonoclot® analysis in whole blood

Thrombosis Research

Volumn 84, Issue 5, 1996, Pages 323-332

  Amirkhosravi, Ali ^a   Biggerstaff, John P ^a   Warnes, Gary ^a   Francis, Debby A ^a   Francis, John L ^a,b  

^a Walt Disney Mem Cancer Inst F   (United States)

^b Hemostasis and Thromb Res Unit   (United States)

Author keywords

cancer; coagulation; Sonoclot analysis; tissue factor

Indexed keywords

THROMBOPLASTIN;

ANIMAL CELL; ARTICLE; ASSAY; BLOOD CLOTTING; CANCER; COMPLICATION; CONTROLLED STUDY; HUMAN; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL; RAT; TUMOR CELL LINE;

ANIMALS; BLOOD COAGULATION FACTORS; BREAST NEOPLASMS; COLONIC NEOPLASMS; FEMALE; HUMANS; MACROPHAGES; MELANOMA; RATS; REAGENT KITS, DIAGNOSTIC; TUMOR CELLS, CULTURED; URINARY BLADDER NEOPLASMS;

EID: 0030561304     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0049-3848(96)00196-X     Document Type: Article

References (38)

1. TROUSSEAU, A. Phlegmasia alba dolens. In: Clinique Medicale de l'Hotel de Paris. Anonymous pp. 654-656, Balliere, (1865).
2. BICK, R.L. Alterations of hemostasis in malignancy. In: Hematology. Clinical and Laboratory Practice. R.L. Bick, J.M. Bennett, R.K. Brynes, M. Cline, L. Kass, G. Murano, S.B. Shohet and P.C.J. Ward (eds.), pp. 1583-1602, Mosby-Year Book Inc, St Louis (1993).
3. BICK R.L. Coagulation abnormalities in malignancy - a review. Semin. Thromb. Hemostasis. 18:1992;353-372.
4. RICKLES F.R., EDWARDS R.L. Activation of blood coagulation in cancer: Trousseau's syndrome revisited. Blood. 62:1983;14-31.
5. SUN N.C.J., MCAFEE W.M., HUM G.J., WEINER J.M. Hemostatic abnormalities in malignancy, a prospective study of one hundred eight patients. Part 1. Coagulation studies Am. J. Clin. Pathol. 71:1979;10-16.
6. RAO L.V.M. Tissue factor as a tumor procoagulant. Cancer Metastasis Rev. 11:1992;249-266.
7. EDWARDS R.L., SILVER J., RICKLES F.R. Human tumor procoagulants: Registry of the Subcommittee of Haemostasis of the Scientific and Standardization Committee, International Society on Thrombosis and Haemostasis. Thromb. Haemost. 69:1993;205-213.
8. GORDON S.G., FRANKS J.J., LEWIS B. Cancer procoagulant: A factor X-activating procoagulant from malignant tissue. Thromb. Res. 6:1975;127-137.
9. VAN DE WATER L., TRACY P.B., ARONSON D., MANN K.G., DVORAK H.F. Tumor cell generation of thrombin via functional prothrombinase assembly. Cancer Res. 45:1985;5521-5525.
10. DVORAK H.F., VAN DE WATER L., BITZER A.M., DVORAK A.M., ANDERSON D., HARVEY V.S., BACH R., DAVIS G.L., DE WOLF W., CARVALHO A.C.A. Procoagulant activity associated with plasma membrane vesicles shed by cultured tumor cells. Cancer Res. 43:1983;4334-4342.
11. GASIC G.J., GASIC T.B., GALANTI N., JOHNSON T., MURPHY S. Platelet-tumor cell interactions in mice. The role of platelets in the spread of malignant disease. Int. J. Cancer. 11:1973;704-718.
12. OLEKSOWICZ L., MROWIEC Z., SCHWARTZ E., KHORSHIDI M., DUTCHER J.P., PUSZKIN E. Characterization of tumor-induced platelet aggregation: The role of immunorelated GPIb and GPIIb/IIIa expression by MCF-7 breast cancer cells. Thromb. Res. 79:1995;261-274.
13. EDWARDS R.L., MORGAN D.L., RICKLES F.R. Animal tumor procoagulants: Registry of the Subcommittee on Haemostasis and Malignancy of the Scientific and Standardization Committee, International Society of Thrombosis and Haemostasis. Thromb. Haemost. 63:1990;133-138.
14. ALEXANDER, P., MURPHY, P. AND SKIPPER, D. Preferential growth of blood-borne cancer cells at sites of metastasis - A growth promoting role of macrophages. In: Cancer Metastasis. G. Prodi, L.A. Liotta, P. Lollini, S. Garbisa, S. Gorini and K. Hellman (eds.), pp. 245-251, Plenum Press, New York (1988).
15. DVORAK H.F., SENGER D.R., DVORAK A.M. Fibrin as a component of the tumor stroma: origins and biological significance. Cancer Metast. Rev. 2:1983;41-73.
16. ZACHARSKI L.R., MEMOLI V.A., COSTANTINI V., WOJTUKIEWICZ M.Z., ORNSTEIN D.L. Clotting factors in tumour tissue: implications for cancer therapy. Blood Coagulat. Fibrinol. 1:1990;71-78.
17. KADISH J.L., WENE K.M., DVORAK H.F. Tissue factor activity of normal and neoplastic cells: Quantitation and species specificity. J. Natl. Cancer Inst. 70:1983;551-557.
18. MUSSONI L., CONFORTI G., GAMBACORTI-PASSERINI C., ALESSIO G., PEPE S., VAGHI M., ERBA E., AMATO G., LANDONI F., MANGIONI C., MORASCA L., SEMERARO N., DONATI M.B. Procoagulant and fibrinolytic activity of human ovarian carcinoma cells in culture. Eur. J. Cancer. Clin. Oncol. 22:1986;373-380.
19. CAJOT J., KRUITHOF E.K.O., SCHEUNLING W., SORDAT B., BACHMANN F. Plasminogen activators, plasminogen activator inhibitors and procoagulant analysed in twenty human tumor cell lines. Int. J. Cancer. 38:1986;719-727.
20. SZCZEPANSKI M., BARDADIN K., ZAWADZKI J., PYPNO W. Procoagulant activity of gastric, colorectal, and renal cancer is factor VII-dependent. J. Cancer Res. Clin. Oncol. 114:1988;519-522.
21. ZACHARSKI L.R., SCHNED A.R., SORENSON G.D. Occurrence of fibrin and tissue factor antigen in human small cell carcinoma of the lung. Cancer Res. 43:1983;3963-3968.
22. CALLANDER N.S., VARKI N., RAO L.V.M. Immunohistochemical identification of tissue factor in solid tumors. Cancer. 70:1992;1194-1201.
23. EDWARDS R.L., RICKLES F.R., CRONLUND M. Abnormalities of blood coagulation in patients with cancer. Mononuclear cell tissue factor generation. J. Lab. Clin. Invest. 98:1981;917-928.
24. CONSTANTINI V., ZACHARSKI L.R., MEMOLI V.A., KISIEL W., KUDRYK B.J., ROUSSEAU S.M. Fibrinogen deposition without thrombin generation in primary human breast cancer tissue. Cancer Res. 51:1991;349-353.
25. ORNSTEIN D.L., ZACHARSKI L.R., MEMOLI V.A., KISIEL W., KUDRYK B.J., HUNT J., ROUSSEAU S.M., STUMP D.C. Coexisting macrophage-associated fibrin formation and tumor cell urokinase in squamous cell and adenocarcinoma of the lung tissue. Cancer. 68:1991;1061-1067.
26. GORDON S.G. Cancer procoagulant. Methods In Enzymology. 244:1994;568-583.
27. FRANCIS J.L., EL-BARUNI K., ROATH O.S., TAYLOR I. Factor X-activating activity in normal and malignant colorectal tissue. Thromb. Res. 52:1988;207-217.
28. EL-BARUNI K., TAYLOR I., ROATH O.S., FRANCIS J.L. Factor X-activating procoagulant in normal and malignant breast tissue. Hematol. Oncol. 8:1990;323-332.
29. FASCO M.J., WILSON A.C., LINCOLN D., GIERTHY J. Evidence for a warfarin-sensitive serum factor that participates in factor X activation by Lewis Lung tumor cells. Int. J. Cancer. 39:1987;631-637.
30. HONN K.V., TANG D.G., CRISSMAN J.D. Platelets and cancer metastasis - a causal relationship. Cancer Metastasis Rev. 11:1992;325-351.
31. HEINMÖLLER E., SCHROPP T., KISKER O., SIMON B., SEITZ R., WEINEL R.J. Tumor cell-induced platelet aggregation in vitro by human pancreatic cancer cell lines. Scand. J. Gastroenterol. 30:1995;1008-1016.
32. AMIRKHOSRAVI M., FRANCIS J.L. Procoagulant effects of the MC28 fibrosarcoma cell line in vitro and in vivo. Brit. J. Haematol. 85:1993;736-744.
33. KARPATKIN S., PEARLSTEIN E. Role of platelets in tumor cell metastases. Ann. Int. Med. 95:1981;636-641.
34. ABECASSIS J., BERETZ A., MILLON-COLLARD R., FRICKER J., EBER M., CAZENAVE J. In vitro interactions between human breast cancer cells MCF-7 and human blood platelets. Thromb. Res. 47:1987;693-698.
35. CHIANG H.-S., YANG R.-S., HUANG T.-F. The Arg-Gly-Asp-containing peptide, rhodostomin, inhibits in vitro cell adhesion to extracellular matrices and platelet aggregation caused by Saos-2 human osteosarcoma cells. Br. J. Cancer. 71:1995;265-270.
36. CHIANG H.-S., SWAIM M.W., HUANG T.-F. Characterization of platelet aggregation induced by human breast carcinoma and its inhibition by snake venom peptides, trigramin and rhodostomin. Breast Cancer Res. Treat. 33:1995;225-235.
37. GORDON S.G. Cancer cell procoagulants and their role in malignant disease. Semin. Thromb. Hemostasis. 18:1992;424-433.
38. BROZNA J.P. Cellular regulation of tissue factor. Blood Coag. Fibrinol. 1:1990;415-426.